A phse II trial of imatinib (IM) in relapsed, nonresectable chondrosarcoma (CS) expressing platelet-derived growth factor receptor-α or -β (PDGFR-α/PDGFR-β): An Italian Sarcoma Group study

被引：0
|
作者：
Grignani, G.
Palmerini, E.
Stacchiotti, S.
Boglione, A.
Ferraresi, V.
Frustaci, S.
Comandone, A.
Casali, P. G.
Ferrari, S.
Aglietta, M.
机构：
[1] Inst Canc Res & Treatment, Candiolo, Italy
[2] Inst Oncol & Ematol, Bologna, Italy
[3] Ist Nazl Tumori, I-20133 Milan, Italy
[4] AO Gradenigo, Turin, Italy
[5] Ist Regina Elena, I-00161 Rome, Italy
[6] Ctr Riferimento Oncol, Aviano, Italy
[7] Osped Gradenigo, Turin, Italy
[8] Ist Ortoped Rizzoli, Bologna, Italy
[9] Univ Turin, Inst Canc Res & Treatment, Candiolo, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.10060
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10060
引用
收藏
页数：1
相关论文
共 20 条
  • [11] Discovery of selective platelet-derived growth factor receptor-beta (PDGFR-?) bifunctional small-molecule degrader br
    Si, Ru
    Liu, Nanxin
    Wang, Jin
    Zhang, Qingqing
    Li, Yanchen
    Pan, Xiaoyan
    Zhang, Jie
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 77
  • [12] Platelet-derived growth factor receptor-β (PDGFR-β) activation promotes its association with the low density lipoprotein receptor-related protein (LRP) -: Evidence for co-receptor function
    Newton, CS
    Loukinova, E
    Mikhailenko, I
    Ranganathan, S
    Gao, YM
    Haudenschild, C
    Strickland, DK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (30) : 27872 - 27878
  • [13] Fibroblast growth factor-2 represses platelet-derived growth factor receptor-α (PDGFR-α) transcription via ERK1/2-dependent Sp1 phosphorylation and an atypical cis-acting element in the proximal PDGFR-α promoter (vol 279, pg 2377, 2004)
    Bonello, MR
    Khachigian, LM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (02) : 1704 - 1704
  • [14] Correlation of vascular endothelial growth factor receptor 2 (VEGFR-2) with platelet-derived growth factor receptor α (PDGFR-α) on circulating epithelial tumor cells (CETCs) in breast cancer patients.
    Pizon, Monika
    Schott, Dorothea
    Pachmann, Ulrich A.
    Pachmann, Katharina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [15] Phase II trial of high dose imatinib in recurrent glioblastoma multiforme (GBM) with platelet derived growth factor receptor (PDGFR) expression
    Viola, F. S.
    Katz, A.
    Arantes, A.
    Gaiger, A.
    Vasconcellos, C.
    Passos, V.
    Barrios, C. H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [16] Immunohistochemical Overexpression of Platelet-Derived Growth Factor Receptor-Beta (PDGFR-β) is Associated With PDGFRB Gene Copy Number Gain in Sarcomatoid Non-Small-Cell Lung Cancer
    Tsao, Anne S.
    Wei, Wei
    Kuhn, Elisabetta
    Spencer, Loreto
    Solis, Luisa M.
    Suraokar, Milind
    Lee, J. Jack
    Hong, Waun Ki
    Wistuba, Ignacio I.
    [J]. CLINICAL LUNG CANCER, 2011, 12 (06) : 369 - 374
  • [17] Imatinib mesylate (GLEEVEC™) induces rapid and complete hematologic remissions in patients with idiopathic hypereosinophilic syndrome (HES) without evidence of BCR-ABL or activating mutations in C-KIT and platelet-derived growth factor receptor-beta (PDGFR-β).
    Gotlib, J
    Malone, JM
    DeAngelo, DJ
    Stone, RM
    Gilliland, DG
    Clark, J
    Tefferi, A
    Alam, R
    Schrier, SL
    Coutre, SE
    [J]. BLOOD, 2002, 100 (11) : 798A - 798A
  • [18] Correlative results of in-vivo monitoring of platelet-derived growth factor receptor (PDGFR) activation status in a randomized placebo-controlled trial of docetaxel± imatinib in castration-resistant prostate cancer (CRPC) and bone metastases (BM)
    Mathew, P.
    Thall, P. F.
    Wen, S.
    Horne, E.
    Johnson, M.
    Oh, W. K.
    Morris, M. J.
    Logothetis, C. J.
    Fidler, I. J.
    Bucana, C.
    [J]. EJC SUPPLEMENTS, 2006, 4 (12): : 28 - 28
  • [19] Better-surviving liver grafts by the injection of anti-CD2 antibody:: The important roles of host CD8+ and CD2+CD28+ T cells in chronic graft rejection and β type platelet-derived growth factor receptor (PDGFR-β) expression on apoptotic liver grafts
    Nakatsuji, T
    [J]. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 187 (03): : 215 - 225
  • [20] Targeting the tyrosine kinase platelet-derived growth factor beta-receptor (PDGFR-b) in advanced gastrointestinal malignanciesa phase I dose escalation study with imatinib in combination with 5-fluorouracil (5-FU) based chemotherapy
    Atmaca, A.
    Al-Batran, S. E.
    Neumann, A.
    Karbach, J.
    Schmidt, S. M.
    Schleyer, E.
    Hosius, C.
    Jaeger, E.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 219 - 219
12